Cardinal Health to acquire Integrated Oncology Network, a physician-led independent community oncology network
Cardinal Health (NYSE: CAH) has announced a definitive agreement to acquire Integrated Oncology Network (ION) for $1.115 billion in cash. ION is a physician-led independent community oncology network with over 50 practice sites across 10 states, representing more than 100 providers. This acquisition aligns with Cardinal Health's strategy to invest in specialty and oncology services, particularly supporting independent community healthcare providers.
The transaction will integrate ION practices into Navista, Cardinal Health's oncology practice alliance. ION's comprehensive care services, including medical oncology, radiation oncology, and urology, will enhance Navista's advanced services and technology offerings. The acquisition is expected to be accretive to non-GAAP earnings per share after 12 months following the close, subject to customary closing conditions and regulatory approvals.
Cardinal Health (NYSE: CAH) ha annunciato un accordo definitivo per acquisire Integrated Oncology Network (ION) per 1,115 miliardi di dollari in contante. ION è una rete di oncologia comunitaria indipendente guidata da medici, con oltre 50 sedi di pratica in 10 stati, che rappresentano più di 100 fornitori. Questa acquisizione si allinea con la strategia di Cardinal Health di investire in servizi specializzati e oncologici, sostenendo in particolare i fornitori di assistenza sanitaria comunitaria indipendenti.
La transazione integrerà le pratiche di ION in Navista, l'alleanza per la pratica oncologica di Cardinal Health. I servizi di assistenza completi di ION, che includono oncologia medica, oncologia radioterapica e urologia, miglioreranno i servizi avanzati e le offerte tecnologiche di Navista. Si prevede che l'acquisizione sarà accretiva per gli utili per azione non-GAAP dopo 12 mesi dalla chiusura, soggetta a condizioni di chiusura consuete e approvazioni normative.
Cardinal Health (NYSE: CAH) ha anunciado un acuerdo definitivo para adquirir Integrated Oncology Network (ION) por $1.115 mil millones en efectivo. ION es una red de oncología comunitaria independiente liderada por médicos, con más de 50 sitios de práctica en 10 estados, que representan a más de 100 proveedores. Esta adquisición se alinea con la estrategia de Cardinal Health de invertir en servicios especializados y oncológicos, apoyando especialmente a los proveedores de atención médica comunitaria independientes.
La transacción integrará las prácticas de ION en Navista, la alianza de prácticas oncológicas de Cardinal Health. Los servicios de atención integral de ION, que incluyen oncología médica, oncología radioterapéutica y urología, mejorarán los servicios avanzados y las ofertas tecnológicas de Navista. Se espera que la adquisición sea acretiva para las ganancias por acción no-GAAP después de 12 meses tras el cierre, sujeta a condiciones de cierre habituales y aprobaciones regulatorias.
카디오날 헬스(Cardinal Health)(NYSE: CAH)는 통합 종양 네트워크(ION)를 11.15억 달러 현금으로 인수하기 위한 최종 계약을 발표했습니다. ION은 10개 주에 걸쳐 50개 이상의 진료소를 보유한 의사 주도의 독립 커뮤니티 종양 네트워크입니다. 이번 인수는 독립 커뮤니티 의료 제공자를 지원하는 특수 및 종양 서비스에 투자하려는 카디오날 헬스의 전략과 일치합니다.
이번 거래는 ION의 진료를 카디오날 헬스의 종양 학회 동맹인 나비스타(Navista)에 통합할 것입니다. ION의 포괄적 치료 서비스에는 의학적 종양학, 방사선 종양학 및 비뇨기과가 포함되어 있으며, 나비스타의 고급 서비스 및 기술 제공을 개선할 것입니다. 인수는 관례적인 종결 조건과 규제 승인을 조건으로 하여 종결 후 12개월 후 비-GAAP 주당 수익에 기여할 것으로 예상됩니다.
Cardinal Health (NYSE: CAH) a annoncé un accord définitif pour acquérir le Integrated Oncology Network (ION) pour 1,115 milliard de dollars en espèces. ION est un réseau d'oncologie communautaire indépendant dirigé par des médecins, avec plus de 50 sites de pratique dans 10 États, représentant plus de 100 prestataires. Cette acquisition s'inscrit dans la stratégie de Cardinal Health d'investir dans des services spécialisés et oncologiques, soutenant en particulier les fournisseurs de soins de santé communautaires indépendants.
La transaction intégrera les pratiques d'ION dans Navista, l'alliance de pratique en oncologie de Cardinal Health. Les services de soins complets d'ION, y compris l'oncologie médicale, l'oncologie radiothérapie et l'urologie, amélioreront les services avancés et les offres technologiques de Navista. L'acquisition devrait être accrétoire pour le bénéfice par action non-GAAP après 12 mois suivant la clôture, sous réserve des conditions de clôture habituelles et des approbations réglementaires.
Cardinal Health (NYSE: CAH) hat eine endgültige Vereinbarung zur Übernahme des Integrated Oncology Network (ION) für 1,115 Milliarden US-Dollar in bar bekannt gegeben. ION ist ein von Ärzten geführtes unabhängiges Netzwerk für Gemeinschaftsonkologie mit mehr als 50 Praxisstandorten in 10 Bundesstaaten, das mehr als 100 Anbieter repräsentiert. Diese Übernahme passt zu Cardinal Healths Strategie, in Spezial- und Onkologieservices zu investieren, insbesondere um unabhängige Anbieter von Gesundheitsdiensten in der Gemeinschaft zu unterstützen.
Die Transaktion wird die ION-Praxen in Navista, die Onkologie-Praxisallianz von Cardinal Health, integrieren. Die umfassenden Pflegeleistungen von ION, zu denen medizinische Onkologie, Strahlenonkologie und Urologie gehören, werden die fortschrittlichen Dienstleistungen und Technologieangebote von Navista verbessern. Die Übernahme wird voraussichtlich nach 12 Monaten nach dem Abschluss akretiv für das nicht-GAAP Ergebnis je Aktie sein, vorbehaltlich der üblichen Abschlussbedingungen und regulatorischen Genehmigungen.
- Acquisition of ION for $1.115 billion expands Cardinal Health's oncology network
- Addition of over 50 practice sites and 100+ providers across 10 states
- Expected to be accretive to non-GAAP earnings per share after 12 months
- Enhances Navista's advanced services and technology offerings
- Strengthens Cardinal Health's position in specialty and oncology markets
- Significant cash outlay of $1.115 billion for the acquisition
- Integration challenges may arise when combining ION with existing operations
- Regulatory approvals required, which could potentially delay or complicate the deal
Cardinal Health's
Key financial implications include:
- Strengthened market position in the growing oncology sector
- Diversification of revenue streams through expanded service offerings
- Potential for synergies and cost efficiencies in the long term
This acquisition marks a strategic pivot for Cardinal Health, intensifying its focus on specialty care and community-based oncology services. The move aligns with broader industry trends of vertical integration and the shift towards value-based care models in oncology.
Key implications include:
- Enhanced support for independent oncology practices, potentially slowing consolidation trends
- Expanded reach in the oncology care continuum, from diagnostics to treatment
- Leveraging of AI and advanced analytics to improve clinical and business outcomes
The integration of ION into Cardinal Health's Navista platform represents a significant technological advancement in community oncology care. By combining ION's practice management services with Navista's AI-driven analytics and Specialty Networks' PPS Analytics and SoNaR solutions, Cardinal is creating a powerful tech ecosystem for oncology practices.
Key tech aspects:
- AI-powered insights for clinical decision-making and business operations
- Enhanced data analytics capabilities across the care continuum
- Improved interoperability and practice management tools
- Transaction demonstrates Cardinal Health's continued strategic investment in specialty and oncology, underscores commitment to independent community healthcare providers
- Accelerates the development of Navista oncology practice alliance, adding more than 100 providers at more than 50 community-based sites delivering broad-reaching oncology and urology care across 10 states
The transaction builds on Cardinal Health's commitment to helping community healthcare providers maintain their independence. As part of the transaction ION practices will become members of Navista, Cardinal Health's oncology practice alliance, and ION practice management and practice growth services will become part of Navista's advanced services and technology offering. ION practices will also have access to Navista's advanced analytics capabilities that leverage artificial intelligence as well as deep expertise from Specialty Networks' PPS Analytics and SoNaR technology solutions to generate actionable clinical and business insights.
"Driving growth in specialty continues to be a top priority, and we've made investments to expand our offerings through both Navista and our acquisition of Specialty Networks," said Jason Hollar, CEO, Cardinal Health. "With their proven model providing extensive support of community oncology across the cancer care continuum and healthcare ecosystem, we're confident Integrated Oncology Network will further accelerate our oncology strategy and enable us to create value for providers and patients."
ION's business model and services are flexible and meet member practices where they are. Its support services include revenue cycle management, payor relations, physician recruitment, practice marketing, finance, accounting, human resources and information technology. Taken together with Navista offerings such as its technology platform and value-based care and ancillary services, ION complements and will expand Cardinal Health's holistic suite of clinical and practice management solutions designed to support independent community oncology practices.
"Integrated Oncology Network and Cardinal Health share a mission of helping community oncology practices deliver world-class patient care and a world-class patient experience to patients and families close to home," said Barry Tanner, CEO, Integrated Oncology Network. "This partnership will give community practices the tools and technology they need to enhance and grow that mission and make a positive impact on patient outcomes."
"By joining forces, Integrated Oncology Network and Cardinal Health are making an exciting commitment to community oncology and, most importantly, to the patients we serve across the country," said Jedidiah Monson, MD, founding partner and president of ION member practice California Cancer Associates for Research & Excellence (cCARE). "By joining Navista, cCARE can access the advanced services and technology we need to remain focused on providing high-quality, lower-cost patient-centered cancer care while staying independent—for the good of our patients, our practices and our communities."
Cardinal Health's Pharmaceutical and Specialty Solutions segment operates one of the largest pharmaceutical supply chains in the
This transaction is subject to the satisfaction of customary closing conditions, including receipt of required regulatory approvals. The transaction is expected to be accretive to non-GAAP earnings per share after 12 months following close.
About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With more than 50 years in business, operations in more than 30 countries and approximately 48,000 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.
About Integrated Oncology Network
Integrated Oncology Network partners directly with physicians, hospitals and other healthcare providers to offer the latest services and technologies to their patients. Founded in 2008, ION has grown to more than 50 centers across the country, providing a complete and integrated continuum of care including diagnostic testing, radiation oncology, medical oncology, urology and other ancillary services. For more information, visit www.ionetwork.com.
Contacts
Media: Andrea Bunce, Andrea.Bunce@cardinalhealth.com and (614) 553-3853
Investors: Matt Sims, Matt.Sims@cardinalhealth.com and (614) 553-3661
Cautions Concerning Forward-Looking Statements
This news release contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. These statements may be identified by words such as "expect," "anticipate," "intend," "plan," "believe," "will," "should," "could," "would," "project," "continue," "likely," and similar expressions, and include statements reflecting future results or guidance, statements of outlook, and various accruals and estimates. These matters are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. These risks and uncertainties include risks associated with our planned acquisition of Integrated Oncology Network, including the risk that we may not receive required regulatory approval or otherwise fail to complete the acquisition and the risk that we may fail to realize the anticipated strategic and financial benefits. Cardinal Health is subject to additional risks and uncertainties described in Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports. This news release reflects management's views as of September 20, 2024. Except to the extent required by applicable law, Cardinal Health undertakes no obligation to update or revise any forward-looking statement. Forward-looking statements are aspirational and not guarantees or promises that goals, targets or projections will be met, and no assurance can be given that any commitment, expectation, initiative or plan in this news release can or will be achieved or completed.
View original content to download multimedia:https://www.prnewswire.com/news-releases/cardinal-health-to-acquire-integrated-oncology-network-a-physician-led-independent-community-oncology-network-302254191.html
SOURCE Cardinal Health
FAQ
What is the value of Cardinal Health's acquisition of Integrated Oncology Network (ION)?
How many practice sites and providers will Cardinal Health gain from the ION acquisition?
When is the Cardinal Health-ION acquisition expected to be accretive to earnings?
What services does Integrated Oncology Network (ION) provide?
How will the ION acquisition impact Cardinal Health's Navista oncology practice alliance?
